← back to search

Kefeng Wang

Bristol-Myers Squibb (United States) · US
🔎 Find collaborators in Epidemiology · Rehabilitation →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Epidemiology · Rehabilitation
Research interest
Research interests include Acute Ischemic Stroke Management, Stroke Rehabilitation and Recovery, Atrial Fibrillation Management and Outcomes, and Epigenetics and DNA Methylation.
h-index
23
citations
1,349
works
95
NIH funding
primary concept
email

Recent publications

Flexible Ureteroscopy with a Flexible and Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for Treatment of 2–3 cm Renal Stones: An International, Multicenter, Randomized, Noninferiority Trial
European Urology 2025cited by 28position: middledoi
Sex and Race‐Ethnic Disparities in Door‐to‐CT Time in Acute Ischemic Stroke: The Florida Stroke Registry
Journal of the American Heart Association 2021cited by 24position: middledoi
Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation
Stroke 2019cited by 60position: middledoi
Race-Ethnic Disparities in 30-Day Readmission After Stroke Among Medicare Beneficiaries in the Florida Stroke Registry
Journal of Stroke and Cerebrovascular Diseases 2019cited by 25position: middledoi
Patterns and Outcomes of Endovascular Therapy in Mild Stroke
Stroke 2019cited by 25position: middledoi
Racial‐Ethnic Disparities in Acute Stroke Care in the Florida‐Puerto Rico Collaboration to Reduce Stroke Disparities Study
Journal of the American Heart Association 2017cited by 58position: middledoi
Stroke Hospital Characteristics in the Florida–Puerto Rico Collaboration to Reduce Stroke Disparities Study
Southern Medical Journal 2017cited by 11position: middledoi
Intersocietal Accreditation Commission Accreditation Status of Outpatient Cerebrovascular Testing Facilities Among Medicare Beneficiaries
Journal of Ultrasound in Medicine 2016cited by 12position: middledoi
First‐line combination of gemcitabine, oxaliplatin, and L‐asparaginase (GELOX) followed by involved‐field radiation therapy for patients with stage IE/IIE extranodal natural killer/T‐cell lymphoma
Cancer 2012cited by 202position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tatjana Rundek · University of Miami6 papers (2016–2021)Chuanhui Dong · University of Miami6 papers (2016–2021)Ralph L. Sacco · Lotus Clinical Research5 papers (2017–2021)José G. Romano · University of Miami5 papers (2017–2021)Carolina M Gutierrez · University of Miami4 papers (2019–2021)Hannah Gardener · University of Miami4 papers (2017–2019)Mary Robichaux · Riverside Community Hospital3 papers (2017–2019)Ulises Nobo · Universidad San Pablo2 papers (2017–2019)Sebastian Koch · Ernst Abbe University of Applied Sciences Jena2 papers (2019–2019)Maria A Ciliberti-Vargas · University of Miami2 papers (2017–2019)Negar Asdaghi · University of Miami2 papers (2019–2021)Juan Carlos Zevallos · University of South Florida2 papers (2019–2019)Scott C. Brown · University of Miami1 papers (2016–2016)Yunfei Xia · Tongji University1 papers (2012–2012)Michael Lilly · Medical University of South Carolina1 papers (2016–2016)Zhongjun Xia · Sun Yat-sen University1 papers (2012–2012)Joann M. Lohr · University of South Carolina1 papers (2016–2016)James F. Benenati · University of South Florida1 papers (2016–2016)Ya-Jun Li · Central South University1 papers (2012–2012)Gary V. Heller · University of Connecticut1 papers (2016–2016)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Epidemiology · Rehabilitation →